International, collaborative assessment of 146 000 prenatal karyotypes: expected limitations if only chromosome-specific probes and fluorescent in-situ hybridization are used
Mi. Evans et al., International, collaborative assessment of 146 000 prenatal karyotypes: expected limitations if only chromosome-specific probes and fluorescent in-situ hybridization are used, HUM REPR, 14(5), 1999, pp. 1213-1216
The development of chromosome-specific probes (CSP) and fluorescent in-situ
hybridization (FISH) has allowed for very rapid identification of selected
numerical abnormalities. We attempt here to determine, in principle, what
percentage of abnormalities would be detectable if only CSP-FISH were perfo
rmed without karyotype for prenatal diagnosis. A total of 146 128 consecuti
ve karyotypes for prenatal diagnosis from eight centres in four countries f
or 5 years were compared with predicted detection if probes for chromosomes
13, 18, 21, X and Y were used, and assuming 100% detection efficiency. A t
otal of 4163 abnormalities (2.85%) were found including 2889 (69.4%) (triso
my 21, trisomy 18, trisomy 13, numerical sex chromosome abnormalities, and
triploidies) which were considered detectable by FISH. Of these, 1274 were
mosaics, translocations, deletions, inversions, rings, and markers which wo
uld not be considered detectable. CSP-FISH is a useful adjunct to karyotype
for high risk situations, and may be appropriate in low risk screening, bu
t should not be seen as a replacement for karyotype as too many structural
chromosome abnormalities will be missed.